46 results on '"Elbekai, Reem"'
Search Results
2. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats
3. Regulatory Forum Opinion Piece*: Retrospective Evaluation of Doses in the 26-week Tg.rasH2 Mice Carcinogenicity Studies: Recommendation to Eliminate High Doses at Maximum Tolerated Dose (MTD) in Future Studies
4. Integration of Pig-a, micronucleus, chromosome aberration and comet assay endpoints in a 28-day rodent toxicity study with urethane
5. The 26-Week Tg.Rash2 Mice Carcinogenicity Studies: Microscopic Examination of Only Select Tissues in Low- and Mid-dose Groups
6. Relationship of Body Weight Parameters with the Incidence of Common Spontaneous Tumors in Tg.rasH2 Mice
7. Carcinogenicity Studies
8. Arsenite and cadmium, but not chromium, induce NAD(P)H:quinone oxidoreductase 1 through transcriptional mechanisms, in spite of post-transcriptional modifications
9. A Proposal for New Strategies in Dose Selection for 26-Week Tg.Rash2 Carcinogenicity Studies
10. Incidence of Spontaneous Non-Neoplastic Lesions in Transgenic CBYB6F1-Tg(HRAS)2Jic Mice
11. Ascorbic acid differentially modulates the induction of heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase Ya by As 3+, Cd 2+ and Cr 6+
12. The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As 3+, Cd 2+, and Cr 6+
13. Cytochrome P450 enzymes: Central players in cardiovascular health and disease
14. The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+
15. A Comparison of Spontaneous Tumors in Tg.rasH2 Mice in 26-week Carcinogenicity Studies Conducted at a Single Test Facility during 2004 to 2012 and 2013 to 2018
16. Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies
17. Exudative Inflammatory Lesions in the Nasal Cavities of the 26-Week Tg.rasH2 Mice Oral Gavage Carcinogenicity Studies
18. A Comparison of Spontaneous Tumors in Tg.rasH2 Mice in 26-week Carcinogenicity Studies Conducted at a Single Test Facility during 2004 to 2012 and 2013 to 2018.
19. Progression of Serosal Vascular Proliferative Lesions to Hemangiosarcomas in the Uterus of the 26-Week Tg.rasH2 Mice Carcinogenicity Studies
20. Renal Tumors in 26-Week Tg.Rash2 Mice Carcinogenicity Studies
21. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy
22. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue®transgenic F344 rats
23. Regulatory Forum Opinion Piece*
24. Exudative Inflammatory Lesions in the Nasal Cavities of the 26-Week Tg.rasH2 Mice Oral Gavage Carcinogenicity Studies.
25. Progression of Serosal Vascular Proliferative Lesions to Hemangiosarcomas in the Uterus of the 26-Week Tg.rasH2 Mice Carcinogenicity Studies.
26. Trend Analysis of Body Weight Parameters, Mortality, and Incidence of Spontaneous Tumors in Tg.rasH2 Mice
27. Exudative inflammatory lesions in the nasal cavity in 28-day dose range finding studies in CByB6F1 mice and in 26-week carcinogenicity studies in Tg.rasH2 mice
28. Toxicity and Biodistribution of the Serotype 2 Recombinant Adeno-Associated Viral Vector, Encoding Aquaporin-1, after Retroductal Delivery to a Single Mouse Parotid Gland
29. Relationship of Body Weight Parameters with the Incidence of Common Spontaneous Tumors in Tg.rasH2 Mice
30. The 26-Week Tg.Rash2 Mice Carcinogenicity Studies
31. Historical control data of neoplatic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice
32. Trend analysis of body weights, survival, and tumor incidence, and the effect of body weight on the incidence of spontaneous tumors in Tg.rasH2 mice
33. Historical control database of non-neoplastic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice
34. Regulatory Forum Opinion Piece*.
35. Regulation of CYP1A1 by heavy metals and consequences for drug metabolism
36. Selective Inhibitors of CYP2J2 Related to Terfenadine Exhibit Strong Activity against Human Cancers in Vitro and in Vivo
37. Ascorbic acid differentially modulates the induction of heme oxygenase-1, NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase Ya by As3+, Cd2+ and Cr6+
38. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats.
39. The Effect of Liver Cirrhosis on the Regulation and Expression of Drug Metabolizing Enzymes
40. Benzo[a]Pyrene, 3-Methylcholanthrene and ß-Naphthoflavone Induce Oxidative Stress in Hepatoma Hepa 1c1c7 Cells by an AHR-dependent Pathway
41. MG-132 inhibits the TCDD-mediated induction of Cyp1a1 at the catalytic activity but not the mRNA or protein levels in Hepa 1c1c7 cells
42. Transcriptional activation and posttranscriptional modification of Cyp1a1 by arsenite, cadmium, and chromium
43. The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+
44. Benzo[a]Pyrene, 3-Methylcholanthrene and β-Naphthoflavone Induce Oxidative Stress in Hepatoma Hepa 1c1c7 Cells by an AHR-dependent Pathway.
45. Modulation of aryl hydrocarbon receptor-regulated gene expression by arsenite, cadmium, and chromium
46. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.